Methamphetamine Abuse Linked To Long-Term Brain Cell Damage
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Methamphetamine Abuse Linked To Long-Term Brain Cell Damage

BETHESDA, MD -- March 28, 2000 -- New research shows that those who use methamphetamine, often called "meth" or "speed," risk long-term damage to their brain cells similar to that caused by strokes or Alzheimer's disease. In an article published in the March 28 issue of Neurology, scientists at the Harbor-UCLA Medical Center in Torrance, California, used magnetic resonance spectroscopy to take measurements of three parts of the brains of 26 participants who had used methamphetamine and then compared them with measurements of the same regions in the brains of 24 people who had no history of drug abuse.

"While the meth users in this study hadn't used the drug for some time--anywhere from two weeks to 21 months, this research strongly suggests that methamphetamine abuse causes harmful physical changes in the brain that can last for many months and perhaps longer after drug use has stopped," said Dr. Alan I. Leshner, Director, National Institute on Drug Abuse (NIDA).

In their study, Dr. Linda Chang and Dr. Thomas Ernst measured levels of brain chemicals that indicate whether brain cells are healthy or are diseased or damaged.

"We found abnormal brain chemistry in the methamphetamine users in all three brain regions we studied. In one of the regions, the amount of damage is also related to the history of drug use -- those who had used the most methamphetamine had the strongest indications of cell damage," Dr. Chang said.

The researchers found that levels of one chemical marker, N- acetyl-aspartate, were reduced by at least five percent in the methamphetamine abusers. "Many diseases associated with brain cell loss or damage, such as Alzheimer's disease, stroke, and epilepsy, are also associated with reduced N- acetyl-aspartate," said Dr. Ernst. "Reduced concentrations of N-acetyl-aspartate in the drug users' brains suggest that long-term methamphetamine abuse results in loss or damage to neurons, the cells we use in thinking." Two other chemical markers, myo-inositol and choline-containing compounds, are associated with glial cells, which act to support neurons. "Methamphetamine abusers showed increases of 11 percent and 13 percent in levels of these markers compared with normal individuals," Dr. Ernst said. "This suggests an increased number or size of glial cells as a reaction to the injurious effects of methamphetamine."

The researchers, who received funding from NIDA, plan to conduct more extensive studies to determine if these brain changes caused by methamphetamine abuse might be reversed or corrected by treatment.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities